In view of his retirement and to mark the occasion of the third decade of the WHO's Action Programme on Essential Medicines, the Chateau des Penthes in Geneva was the setting for a day long brainstorming consultation titled "The next generation of essential medicines" which was held on May 30, 2011. The grand old men and women, who started the essential medicines movement in WHO, mingled with the next generation health professionals to celebrate 30 years of the Action Programme on Essential Medicines, identify strategic directions for the future and to involve and motivate the next generation of colleagues and experts.
The consultation started with Carissa Etienne, Assistant Director of Health Systems and Services, WHO, welcoming the participants and briefl y describing how the Action Programme on Essential Medicines started. Jonathan Quick moderated the session "How it all began: 1977-1989" with reminiscences by M. Helling-Borda on the fi rst essential medicines list, P. Brudon on the Nairobi Conference in 1985 and comments by E. Lauridsen and former Director-General of WHO, H. Mahler, during a panel discussion "What have we learnt?". The challenges faced by these early stalwarts and how they were overcome set the mood for the rest of the day. The next session was moderated by Kees de Joncheere which was on "The 1990's: Large country programmes on essential medicines". The discussion focused on the essential medicines programs in Sudan, Kenya, South Africa and Vietnam and described the progress that had been made in these countries. The offi cers who had started these programs shared the platform with the present national professional offi cers and shared the progress made, setbacks in implementation and the lessons learnt. After the coffee break, the session was on "The 2000's: New dimensions of the essential medicines concept". Dr. Suzanne Hill, Medicines Access and Rational Use, WHO, spoke on the future of the Model List of Essential Medicines and described the procedural steps that have slowly evolved in the process of preparation of the WHO model essential medicines list and the children's list. Gitanjali Batmanabane spoke next on the "Essential Medicines for Children in India" and described the "Better Medicines for Children" project in India. She explained the pricing and availability surveys that had been conducted in Chhattisgarh and Orissa and the essential medicines for children which have been included in the state essential medicines list.
After lunch, there was an interesting session on "The 2010's: Essential medicines within health reform". The essential medicines concept and health reform in China was aptly described by Ye Lu. Richard Laing, Team Leader -Medicine Information and Evidence for Policy, WHO, spoke on the "need for generic policies as part of health reform". The icing on the cake was the last talk of the day "The future of essential medicines" by Hans Hogerzeil, who described his journey of two and a half decades with photographs, anecdotes and
